Exclusive

Publication

Byline

Location

Clinical Trial: Clinical and Radiographic Comparison of SMART Hall and Conventional Hall Techniques in Children With Carious Primary Molars

U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07792551) titled 'Clinical and Radiographic Comparison of SMART Hall and Conventional Hall Techniques in Chil... Read More


Clinical Trial: A Clinical Trial of Resistant Potato Starch for Gut MDRO Decolonization

U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07792915) titled 'A Clinical Trial of Resistant Potato Starch for Gut MDRO Decolonization' on Aug. 11. Brief... Read More


Clinical Trial: Baduanjin for Quality of Life in Pancreatic Cancer Chemotherapy

U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07791550) titled 'Baduanjin for Quality of Life in Pancreatic Cancer Chemotherapy' on Aug. 24. Brief Summary... Read More


Clinical Trial: Effect of Optimal Biological Volume Bupivacaine Liposome Interscalene Brachial Plexus Block on Postoperative Analgesia After Shoulder Arthroscopy

U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07792044) titled 'Effect of Optimal Biological Volume Bupivacaine Liposome Interscalene Brachial Plexus Block... Read More


Clinical Trial: A Study of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab as Maintenance Therapy in Second-Line Platinum-Sensitive Recurrent Ovarian Cancer (REJOICE-Ovarian03)

U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07791732) titled 'A Study of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab as Maintenance Therap... Read More


Singapore Clinical Trial: FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy or Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer, and Sofetabart Mipitecan plus Bevacizumab versus Platinum-Based Chemotherapy plus Bevacizumab in Platinum-Sensitive Ovarian Cancer

Singapore, Aug. 29 -- The Health Sciences Authority received information related to the study titled 'FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy o... Read More


Singapore Clinical Trial: A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Versus Standard of Care as Maintenance Treatment After 2L Platinum-Based Doublet Chemotherapy in Participants With Recurrent Platinum- Sensitive Ovarian Cancer (PSOC)

Singapore, Aug. 29 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Ver... Read More


Singapore Clinical Trial: An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembrolizumab Versus Chemotherapy in Subjects with Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma that Expresses HER2 (IHC 1+ and Greater)

Singapore, Aug. 29 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembr... Read More


Singapore Clinical Trial: A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Platinum-Based Chemotherapy ± Bevacizumab as 2L Treatment in Participants With Recurrent Platinum-Sensitive Ovarian Cancer

Singapore, Aug. 29 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Pl... Read More


Singapore Clinical Trial: ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants with Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

Singapore, Aug. 29 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Com... Read More